Whether you want to believe it or not, the Apple company currently has a secret team of employees trying to produce a revolutionary treatment for diabetes. We are talking about biomedical engineers who were hired by the Apple company in recent months, working in a building in Palo Alto, California, and having the unconditional support of those in Cupertino.
According to those who provide today's information, the Apple company wants to implement in the Apple Watch a series of special sensors that can more accurately monitor the level of glucose in the blood. Having a much more accurate monitoring of blood glucose levels, Apple believes that treatments for diabetes can be much more effective, and the development process is so advanced that Apple has also done feasibility tests for the launch.
We are talking about a series of optical sensors that work by emitting light to the skin to measure the level of glucose in the blood. If Apple succeeds in correctly measuring the level of glucose in the blood, then we are talking about a real revolution in the medical world and not only for the Apple company, its achievements may bring benefits to all those who suffer from diabetes.
Apple is developing a revolutionary treatment for diabetes
The creation of such sensors for the correct measurement of blood glucose is an almost impossible task, according to an expert in the development of such solutions. The realization of this project would cost Apple between several hundred million and one billion dollars, but those from Cupertino have enough resources to achieve everything they need and help the whole world.
It seems that this initiative started when Steve Jobs was still president of the Apple company, so the project would have been under development for more than 5 years. In this period, Apple has certainly invested very large amounts of money to realize its plan, so probably its ideas are good enough to deserve large-scale investments to be launched on the market.
"The initiative is far enough along that Apple has been conducting feasibility trials at clinical sites across the Bay Area and has hired consultants to help it figure out the regulatory pathways, the people said. Accurately detecting glucose levels has been such a challenge that one of the top experts in the space, John L. Smith, described it as "the most difficult technical challenge I have encountered in my career." To succeed would cost a company "several hundred millions or even a billion dollars," DexCom executive chairman Terrance Gregg previously told Reuters."
With these sensors implemented in the Apple Watch and the very accurate measurement of the level of glucose in the blood, the Apple company would have a partial treatment for diabetes because based on this information, doctors can offer much better treatments for the disease.
